Potassium and Takhzyro drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Potassium (potassium) and Takhzyro (lanadelumab-flyo). Common drug interactions include hereditary angioedema among females.
The phase IV clinical study analyzes what interactions people have when they take Potassium and Takhzyro. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.
What is Potassium?
Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.
What is Takhzyro?
Takhzyro has active ingredients of lanadelumab-flyo. eHealthMe is studying from 2,828 Takhzyro users. Check the latest studies of Takhzyro.
26 people who take Potassium and Takhzyro together, and have interactions are studied.
What are the common drug interactions of Potassium and Takhzyro, by gender? *:
female:
- Hereditary angioedema (recurrent episodes of severe swelling)
- Abdominal distension
- Seasonal allergy (allergic condition due to certain season)
- Brain injury
- Migraine (headache)
- Dyspnoea (difficult or laboured respiration)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Chest pain
- Drug hypersensitivity
- Hepatic cyst
male:
n/a
What are the common drug interactions of Potassium and Takhzyro, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Hereditary angioedema (recurrent episodes of severe swelling)
- Seasonal allergy (allergic condition due to certain season)
- Brain injury
- Migraine (headache)
- Chest pain
- Drug hypersensitivity
60+:
- Hereditary angioedema (recurrent episodes of severe swelling)
- Abdominal distension
- Dyspnoea (difficult or laboured respiration)
- Hepatic cyst
- Laryngeal oedema (swelling of larynx)
- Pain
- Rectal haemorrhage (bleeding from anus)
- Tremor (trembling or shaking movements in one or more parts of your body)
What are the existing conditions these people have? *
- Hereditary Angioedema (recurrent episodes of severe swelling): 21 people, 80.77%
- Immune System Disorder: 7 people, 26.92%
* Approximation only. Some reports may have incomplete information.
Do you take Potassium and Takhzyro?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Potassium and Takhzyro:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Potassium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Takhzyro:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Potassium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Takhzyro and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on potassium and lanadelumab-flyo (the active ingredients of Potassium and Takhzyro, respectively), and Potassium and Takhzyro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cisplatin cause Red Blood Cell Sedimentation Rate Increased? - now
- Drug interactions of Paraflex and Oxycodone - 5 seconds ago
- Could Zymar cause Depression? - 5 seconds ago
- Hypercalcaemia and Musculoskeletal Discomfort - 6 seconds ago
- Could Ramipril cause Reversible Ischaemic Neurological Deficit? - 11 seconds ago
- Drug interactions of Acetylcarnitine and Acetylcysteine - 20 seconds ago
- Drug interactions of Veltassa and Lexapro - 26 seconds ago
- Drug interactions of Synthroid and Terconazole - 26 seconds ago
- Could Altace cause Scapula Fracture? - 27 seconds ago
- Drug interactions of Insulin and Mycophenolate Mofetil - 29 seconds ago